It recommended semaglutide be considered for weight loss in people with established cardiovascular disease, like a history of heart attacks, to reduce future risk
Real-world evidence can show payers which subpopulations benefit most and inform more equitable coverage policies
The Chimerix drug, called dordaviprone, is being reviewed by the FDA to treat patients with H3 K27M-mutant diffuse glioma, a rare, high-grade brain tumor that most commonly affects children and young adults
Known by the brand names Ozempic and Wegovy, it is one of the most effective tools available for steady, medically supervised fat loss
So what we know, you know, again, Im going to call back to the The Biggest Loser episode that I did, what we know to be true about people who experience rapid and drastic weight loss is that the exit strategy from that low calorie meal plan is probably more important than the actual low calorie meal plan itself
In general, no therapeutic intervention is required